MNOV insider transaction filings
MEDICINOVA INC — 21 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-25. Screen MNOV transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 3 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| BEAVER CAROLYN — Director | 1 | — | — | 1 |
| Lemerond Nicole — Director | 1 | — | — | 1 |
| Nagao Hideki — Director | 1 | — | — | 1 |
Recent Form 4 filings — MEDICINOVA INC
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Nagao Hideki — Director | Grant/award (A): 44,500 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Lemerond Nicole — Director | Grant/award (A): 44,500 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | BEAVER CAROLYN — Director | Grant/award (A): 44,500 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Matsuda Kazuko — Chief Medical Officer | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | IWAKI YUICHI — President and CEO | Grant/award (A): 450,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Lemerond Nicole — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Nagao Hideki — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | BEAVER CAROLYN — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Nagao Hideki — Director | Grant/award (A): 24,500 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Matsuda Kazuko — Chief Medical Officer, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Lemerond Nicole — Director | Grant/award (A): 24,500 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | IWAKI YUICHI — President and CEO, Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | BEAVER CAROLYN — Director | Grant/award (A): 24,500 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | Matsuda Kazuko — Chief Medical Officer, Director | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-01-10 | 4 | IWAKI YUICHI — President and CEO, Director | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Nagao Hideki — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Lemerond Nicole — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | BEAVER CAROLYN — Director | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | OBrien Geoffrey — Vice President | Grant/award (A): 84,000 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | Matsuda Kazuko — Chief Medical Officer, Director | Grant/award (A): 157,500 (derivative) @ $0 | EDGAR |
| 2024-01-11 | 4 | IWAKI YUICHI — President and CEO, Director | Grant/award (A): 210,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — MEDICINOVA INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-02 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
| 2026-08-19 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-02-20 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-18 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-03-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2024-04-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MNOV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →